Report

Our reports provide latest industry trends, forecasts, company profiles, competitive landscape, and strategic insights.

Asset 41 2
160 1608792 circle document icon png transparent png

Middle East & Africa Genotyping Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product and Services (Instruments, Reagents and Kits, Bioinformatics, and Genotyping Services), Technology [Microarrays, Capillary Electrophoresis, Sequencing, Polymerase Chain Reaction (PCR), Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry, and Others], Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Animal Genetics, Agricultural Biotechnology, and Others), and End User (Pharmaceutical and Biopharmaceutical Companies, Diagnostic and Research Laboratories, Academic Institutes, and Others) 

The genotyping market in Middle East & Africa is expected to grow from US$ 1,141.17 million in 2022 to US$ 3,176.29 million by 2028. It is estimated to grow at a CAGR of 18.6% from 2022 to 2028.

Genotyping compares a DNA sequence to another sample or a reference sequence to discover variations in genetic complement. It detects single-nucleotide polymorphisms (SNPs), which are minor differences in genetic sequence within the population. The human genome has about 660 million SNPs, making them the most prevalent kind of genetic variation. They can explain features such as eye color and hereditary disorders such as cystic fibrosis and sickle cell anemia and serve as indicators for developing complicated diseases such as cancer, diabetes, and Alzheimer’s.

According to the International Diabetes Federation (IDF) Consortium 2019, type 2 diabetes (T2D) is one of the leading causes of death worldwide, accounting for 4.2 million deaths in 2019. According to the same research, Iran ranks third among 20 countries in the Middle East and North Africa (MENA) in terms of the number of adults with diabetes (5.4 million), estimated that about 9.2 million Iranians may catch the disease by 2030. Type 2 diabetes is a complex metabolic illness caused by genetic and non-genetic (environmental) factors. The heritability of T2D varies between 20% and 80%, indicating that genetic factors play a significant part in the disease’s development; the disease’s heritable component is polygenic, meaning that multiple genes and their variations contribute to an increased risk of T2D development. The introduction of high-throughput genotyping technologies has greatly advanced our understanding of the genetic components of complex disorders, such as T2D.

Additionally, by comparing polymorphisms in two distinct populations (one healthy and one diseased), genome-wide association studies (GWAS) can uncover links between SNPs and common illness risk. GWAS can begin to untangle the molecular mechanisms underlying disease states by finding probable causative variables risk stratification. Single-celled organisms, such as bacteria, even have SNPs. SNP genotyping can discriminate between microorganism isolates and might even be accustomed to characterizing antibiotic resistance strains. SNP-based strain detection has relevance in each clinical and pharmaceutical analysis and has been used to study the spread of infectious diseases in humans. Over the last decade, next-generation sequencing (NGS) technology has enabled simultaneous testing of multiple disease genes, from targeted gene panels to exome sequencing (ES) and genomic sequencing (GS). GS is quickly becoming a practical first-stage test as costs decrease and performance improves. More and more studies show that GS can detect an unprecedented range of pathogenic abnormalities in a single laboratory. GS has the potential to provide patients with unbiased, rapid, and accurate molecular diagnostics that transcend diverse clinical indications and complex conditions. Therefore, the use in drug development for genetic and rare diseases will be one of the key factors driving the growth of the genotyping markets during the forecast period.

Middle East & Africa Genotyping Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa Genotyping Market Segmentation

The Middle East & Africa genotyping market is segmented by products and services, technology, application, end user, and country. Based on products and services, the market is segmented into instruments, reagents and kits, bioinformatics, and genotyping services. The reagents and kits segment is dominating the market in 2022.

Based on technology, the market is segmented into microarrays, capillary electrophoresis, sequencing, matrix-assisted laser desorption/ionization-time of flight (Maldi-ToF) mass spectrometry, polymerase chain reaction (PCR), and others. The PCR segment is dominating the market in 2022.

Based on application, the market is segmented into pharmacogenomics, diagnostics and personalized medicine, animal genetics, agricultural biotechnology, and others. The diagnostics and personalized medicine segment is dominating the market in 2022.

Based on end user, the market is segmented into pharmaceutical and biopharmaceutical companies, diagnostic and research laboratories, academic institutes, and others. The diagnostics and research laboratories segment is dominating the market in 2022.

Based on country, the market is segmented into Saudi Arabia, the UAE, South Africa, and the Rest of the Middle East & Africa. Further, the Rest of the Middle East & Africa is dominating the market in 2022.

A few key players dominating the Middle East & Africa genotyping market are BioTek Instruments, Inc.; F. Hoffmann-La Roche Ltd.; Illumina, Inc.; Integrated DNA Technologies, Inc.; MERCK KGaA; QIAGEN; Thermo Fisher Scientific Inc; and TrimGen Corporation.

TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 MEA Genotyping Market – By Product and Services
1.3.2 MEA Genotyping Market – By Technology
1.3.3 MEA Genotyping Market – By Application
1.3.4 MEA Genotyping Market – By End User
1.3.5 MEA Genotyping Market – By Country
2. MEA Genotyping Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. MEA Genotyping Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 MEA PEST Analysis
4.3 Experts Opinion
5. MEA Genotyping Market– Key Market Dynamics
5.1 Market Drivers
5.1.1 Use of Genotyping in Drug Development for Genetic and Rare Diseases
5.1.2 Technological Advancements and Rising R&D Investments in Pharmaceutical and Biotechnology
5.2 Market Restraints
5.2.1 High Cost of Equipment and Shortage of skilled Professionals required for Genotyping process
5.3 Market Opportunities
5.3.1 Wide Applications of Genotyping
5.4 Future Trends
5.4.1 Rising focus on Personalized Medicine
5.5 Impact analysis
6. Genotyping Market– MEA Analysis
6.1 MEA Genotyping Market Revenue Forecast and Analysis
7. MEA Genotyping Market– by Product and Services
7.1 Overview
7.2 MEA Genotyping Market, By Product and Services, 2022 & 2028 (%)
7.3 Reagents and Kits
7.3.1 Overview
7.3.2 Reagents and Kits: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Genotyping Services
7.4.1 Overview
7.4.2 Genotyping Services: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Bioinformatics
7.5.1 Overview
7.5.2 Bioinformatics: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
7.6 Instruments
7.6.1 Overview
7.6.2 Instruments: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
8. MEA Genotyping Market– by Technology
8.1 Overview
8.2 MEA Genotyping Market Share by Technology – 2022 & 2028 (%)
8.3 Polymerase Chain Reaction (PCR)
8.3.1 Overview
8.3.2 Polymerase Chain Reaction: MEA Genotyping Market Revenue and Forecast to 2028 (US$ Million)
8.4 Capillary Electrophoresis (CE)
8.4.1 Overview
8.4.2 Capillary Electrophoresis: MEA Genotyping Market Revenue and Forecast to 2028 (US$ Million)
8.5 Sequencing
8.5.1 Overview
8.5.2 Sequencing: MEA Genotyping Market Revenue and Forecast to 2028 (US$ Million)
8.6 Microarrays
8.6.1 Overview
8.6.2 Microarrays: MEA Genotyping Market Revenue and Forecast to 2028 (US$ Million)
8.7 Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry
8.7.1 Overview
8.7.2 Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry: MEA Genotyping Market Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: MEA Genotyping Market Revenue and Forecast to 2028 (US$ Million)
9. MEA Genotyping Market–by Application
9.1 Overview
9.2 MEA Genotyping Market Share by Application – 2022 & 2028 (%)
9.3 Diagnostics and Personalized Medicine
9.3.1 Overview
9.3.2 Diagnostics and Personalized Medicine: MEA Genotyping Market Revenue and Forecast to 2028 (US$ Million)
9.4 Pharmacogenomics
9.4.1 Overview
9.4.2 Pharmacogenomics: MEA Genotyping Market Revenue and Forecast to 2028 (US$ Million)
9.5 Animal Genetics
9.5.1 Overview
9.5.2 Animal Genetics: MEA Genotyping Market Revenue and Forecast to 2028 (US$ Million)
9.6 Agricultural Biotechnology
9.6.1 Overview
9.6.2 Agricultural Biotechnology: MEA Genotyping Market Revenue and Forecast to 2028 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: MEA Genotyping Market Revenue and Forecast to 2028 (US$ Million)
10. MEA Genotyping Market– by End User
10.1 Overview
10.2 MEA Genotyping Market Share by End User- 2022 & 2028 (%)
10.3 Diagnostic and Research Laboratories
10.3.1 Overview
10.3.2 Diagnostic and Research Laboratories: MEA Genotyping Market Revenue and Forecast to 2028 (US$ Million)
10.4 Pharmaceutical and Biopharmaceutical Companies
10.4.1 Overview
10.4.2 Pharmaceutical and Biopharmaceutical Companies: MEA Genotyping Market Revenue and Forecast to 2028 (US$ Million)
10.5 Academic Institutes
10.5.1 Overview
10.5.2 Academic Institutes: MEA Genotyping Market Revenue and Forecast to 2028 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: MEA Genotyping Market Revenue and Forecast to 2028 (US$ Million)
11. MEA Genotyping Market– Country Analysis
11.1 MEA Genotyping Market Revenue and Forecasts to 2028
11.1.1 Overview
11.1.3 MEA Genotyping Market Revenue and Forecasts to 2028, By Country (%)
11.1.3.1 UAE: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.1.3.1.1 Overview
11.1.3.1.2 UAE: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.1.3.1.3 UAE: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
11.1.3.1.4 UAE: Genotyping Market, by Technology, 2019–2028 (US$ Million)
11.1.3.1.5 UAE: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
11.1.3.1.6 UAE: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11.1.3.2 Saudi Arabia: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.1.3.2.1 Overview
11.1.3.2.2 Saudi Arabia: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.1.3.2.3 Saudi Arabia: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
11.1.3.2.4 Saudi Arabia: Genotyping Market, by Technology, 2019–2028 (US$ Million)
11.1.3.2.5 Saudi Arabia: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
11.1.3.2.6 Saudi Arabia: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11.1.3.3 South Africa: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.1.3.3.1 Overview
11.1.3.3.2 South Africa Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.1.3.3.3 South Africa: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
11.1.3.3.4 South Africa: Genotyping Market, by Technology, 2019–2028 (US$ Million)
11.1.3.3.5 South Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
11.1.3.3.6 South Africa: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11.1.3.4 Rest of MEA: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.1.3.4.1 Overview
11.1.3.4.2 Rest of MEA: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.1.3.4.3 Rest of MEA: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
11.1.3.4.4 Rest of MEA: Genotyping Market, by Technology, 2019–2028 (US$ Million)
11.1.3.4.5 Rest of MEA: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
11.1.3.4.6 Rest of MEA: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)
12. MEA Genotyping Market Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 F. HOFFMANN-LA ROCHE LTD.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 INTEGRATED DNA TECHNOLOGIES, INC. (DANAHER)
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 QIAGEN
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 MERCK KGaA
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 THERMO FISHER SCIENTIFIC INC.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 BioTek Instruments, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 TRIMGEN CORPORATION
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Financial Overview
13.7.4 SWOT Analysis
13.7.5 Key Developments
13.8 Illumina, Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms

LIST OF TABLES

Table 1.             MEA Genotyping Market –Revenue and Forecast to 2028 (US$ Million)
Table 2.             UAE: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
Table 3.             UAE: Genotyping Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 4.             UAE: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 5.             UAE: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 6.             Saudi Arabia: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
Table 7.             Saudi Arabia: Genotyping Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 8.             Saudi Arabia: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 9.             Saudi Arabia: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 10.          South Africa Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
Table 11.          South Africa: Genotyping Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 12.          South Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 13.          South Africa: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 14.          Rest of MEA: Genotyping Market Revenue and Forecasts to 2028, By Product and Services  (US$ Million)
Table 15.          Rest of MEA: Genotyping Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 16.          Rest of MEA: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 17.          Rest of MEA: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 18.          Organic Developments Done By Companies
Table 19.          Inorganic Developments Done By Companies
Table 20.          Glossary of Terms
 
 

LIST OF FIGURES

Figure 1.           MEA Genotyping Market Segmentation
Figure 2.           MEA Genotyping Market – By Country
Figure 3.           MEA Genotyping Market Overview
Figure 4.           Reagents and Kits Held Largest Share by Product and Services of MEA Genotyping Market
Figure 5.           Saudi Arabia to Show Significant Growth During Forecast Period
Figure 6.           MEA: PEST Analysis
Figure 7.           Experts Opinion
Figure 8.           MEA Genotyping Market Impact Analysis of Driver and Restraints
Figure 9.           MEA Genotyping Market– Revenue Forecast and Analysis – 2022 – 2028
Figure 10.        MEA Genotyping Market, by Product and Services, 2022 & 2028 (%)
Figure 11.        Reagents and Kits: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12.        Genotyping Services: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13.        Bioinformatics: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14.        Instruments: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15.        MEA Genotyping Market Share by Technology – 2022 & 2028 (%)
Figure 16.        Polymerase Chain Reaction: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17.        Capillary Electrophoresis: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18.        Sequencing: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19.        Microarrays: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 20.        Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21.        Others: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22.        MEA Genotyping Market Share by Application – 2022 & 2028 (%)
Figure 23.        Diagnostics and Personalized Medicine: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24.        Pharmacogenomics: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25.        Animal Genetics: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 26.        Agricultural Biotechnology: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 27.        Others: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 28.        MEA Genotyping Market Share by End User- 2022 & 2028 (%)
Figure 29.        Diagnostic and Research Laboratories: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 30.        Pharmaceutical and Biopharmaceutical Companies: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 31.        Academic Institutes: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 32.        Others: MEA Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 33.        MEA Genotyping Market Revenue Overview, by Country, 2022 (US$ Million)
Figure 34.        MEA Genotyping Market Revenue and Forecasts to 2028, By Country (%)
Figure 35.        UAE: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 36.        Saudi Arabia: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 37.        South Africa: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 38.          Rest of MEA: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa Genotyping Market.
● Highlights key business priorities in order to assist companies to realign their business strategies
● The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa Genotyping Market, thereby allowing players across the value chain to develop effective long-term strategies
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
● Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Genotyping Market, as well as those hindering it
● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

The List of Companies – Middle East & Africa Genotyping Market

● BioTek Instruments, Inc.
● F. Hoffmann-La Roche Ltd.
● Illumina, Inc.
● Integrated DNA Technologies, Inc.
● MERCK KGaA
● QIAGEN
● Thermo Fisher Scientific Inc
● TrimGen Corporation

Pricing

$3,000.00$5,000.00

Have a Query?

Have a Question?

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

GET FREE SAMPLE PDF

× Enquire Now